Sensible BiotechnologiesEngineering cells to unlock the next generation of mRNA medicines

Sensible Biotechnologies: mRNA. Made Better.

Introduction

Sensible Biotechnologies is revolutionizing the future of mRNA therapeutics and vaccines by leveraging engineered living cells to produce high-quality, stable, and non-immunogenic mRNA in a scalable and cost-effective manner.

Key Features

• Cell-Based mRNA Production: Utilizing engineered living cells for efficient and scalable mRNA manufacturing.
• High-Quality mRNA: Producing abundant, highly stable, and non-immunogenic mRNA.
• Cost-Effective Manufacturing: Reducing costs to improve access to mRNA technology.
• Scalable Production: Enhancing biosecurity and supply chain resilience.
• Innovative Platform: Combining cell engineering, computational biology, and precision fermentation.

Use Cases

• mRNA Vaccines: Developing next-generation vaccines with improved efficacy and stability.
• Therapeutics: Creating novel mRNA-based treatments for various diseases.
• Biosecurity: Strengthening supply chain resilience and biosecurity through scalable production methods.
• Research and Development: Supporting academic and industrial research with high-quality mRNA.

Pricing

Sensible Biotechnologies offers competitive pricing models tailored to the needs of different clients, ensuring cost-effective access to cutting-edge mRNA technology. Contact us for detailed pricing information and custom solutions.

Teams

Our team comprises leading experts in mRNA manufacturing, synthetic biology, and life sciences, including:

• Miroslav Gasparek: Co-Founder and Chief Executive Officer
• Marian Kupculak, DPhil: Co-Founder and Chief Scientific Officer
• Paul Sobotka, MD: Vice President of Clinical Research
• Anton McCaffrey, PhD: Vice President of Manufacturing Strategy
• Leanne Minall, DPhil: Head of Science
• Michal Karlubik: Head of Partnerships & External Affairs
• Akos Melecske, MA: Head of Finance and Operations
• Krishna Motheramgari, PhD: Principal Computational Scientist
• Robert Hieronymus, PhD: Senior Scientist
• Kelvin Yaprianto, DPhil: Senior Scientist
• Liudmyla Kapustian, PhD: Senior Scientist
• Martina Belkova, PhD: Scientist
• Smruti Rashmi, PhD: Scientist
• Neelam Mehta: Scientist and Lab Manager
• Emily Buck: Scientist
• Mario Simo Hernando: Associate Scientist
• Alexandra Vargova: Associate Computational Scientist
• Romana Halova: Scientist
• Dominika Valachova: Associate Scientist
• Vikram Shaw: Research Scientist
• Kazimir Uzwyshyn-Jones: Research Scientist
• Alexandra Korobova: Executive Assistant
• Kristina Balcokova: Associate Scientist

Join our team of experts and contribute to the future of mRNA technology. We are hiring cell engineers, bioprocess engineers, mRNA Quality Control analysts, and RNA computational biologists for our Oxford site. Contact us to learn more about career opportunities.